Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 5/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2989976 | 0.95 | PTGS1 (0.38) | PTGS1PTGS2CA2PTPN1CA1 | |
| SCHEMBL19611303 | 0.93 | PTGS1 (0.39) | PTGS1PTGS2CA2PTPN1CA1 | |
| SCHEMBL2982251 | 0.87 | PTGS1 (0.36) | PTGS1PTGS2CA2PTPN11 | |
| SCHEMBL13266199 | 0.81 | PTGS1 (0.44) | PTGS1PTGS2CA2PTPN1PTPN11 | |
| Lithium SCHEMBL2991326 | 0.80 | PTGS1 (0.43) | PTGS1PTGS2CA2PTPN1PTPN11 | |
| SCHEMBL5017128 | 0.76 | PTPN1 (0.37) | PTGS1PTGS2CA2PTPN1MAPK1 | |
| SCHEMBL2992202 | 0.75 | CA1 (0.35) | PTGS1PTGS2CA2PTPN1SMN1; SMN2 | |
| SCHEMBL2994157 | 0.75 | CA2 (0.47) | CA2PTPN1SMN1; SMN2CA1PTPRZ1 | |
| SCHEMBL5013864 | 0.74 | PTPN1 (0.38) | PTGS1PTGS2CA2PTPN1MAPK1 | |
| SCHEMBL2989007 | 0.73 | CA2 (0.41) | PTGS1PTGS2CA2PTPN1PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853448-B2 | Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | AFF2, ARSA, FGFR2 | PTGS1 4858/4885PTGS2 4527/4885CA2 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.